LG Electronics presents the XD4 Dishwasher, a perfect blend of style, convenience, and intelligent cleaning for households preparing to host cherished ...
The annual general meeting (AGM) took due note of the management's review and discussed and approved the Annual Report 2025 together with the statement by the Executive Board and the Board of Director ...
U.S. Energy Corporation (NASDAQ: USEG, "U.S. Energy" or the "Company") today reported financial and operating results for the fourth quarter and year ended ...
GRAND CAYMAN, Cayman Islands, March 13, 2026 (GLOBE NEWSWIRE) -- Activate Energy Acquisition Corp. (NASDAQ: AEAQ) (the "Company"), a special purpose acquisition company formed for the purpose of ...
New data supports GraftAssure commercialization effortsMulti-center study featured 249 biopsy-matched patientsProprietary "Combination Model" score outperformed percentage-only measures of dd-cfDNARei ...
AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update Phase 2 interim results suggest treatment with active immunotherapy ACI-7104 may slow the progression of Parkinson's ...
Parrot CEO & founder Henri Seydoux together with SEALSQ General Manager Bernard Vian and EMEA Sales Director Fabien Treillaud at Embedded World, Nuremberg, on March 11, 2026. SEALSQ Corp (Nasdaq: LAES ...
Miami, Florida--(Newsfile Corp. - March 13, 2026) - The latest episode of the DesignRush Podcast features Jeff Finkelstein, founder of digital agency Customer Paradigm, explaining why marketing ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing ...
BERKELEY, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: QUCY) doing business as Quantum Cyber, today announced, effective upon the commencement of trading on March 12, 2026 ...
Promising Start to 2026 Across Entire North American Portfolio COLORADO SPRINGS, Colo., March 13, 2026 /PRNewswire/ -- Century Casinos, Inc. (the "Company", "we" ...
FY 2025 net revenue of $272.1 million, flat to FY 2024, and Adjusted EBITDA of $16.1 million Q4 2025 net revenue of $72.0 million, flat to Q4 2024 and Adjusted EBITDA of $6.6 million Obagi Medical see ...